Related Experiment Video
Updated: May 15, 2026
05:43
Topical Airway Anesthesia for Awake-endoscopic Intubation Using the Spray-as-you-go Technique with High Oxygen Flow
Published on: January 13, 2017
Pyopneumothorax following suicidal kerosene ingestion
S K Verma1, Neha Kapoor, Ravi Bhaskar
1Department of Pulmonary Medicine, King George's Medical University, Lucknow, Uttar Pradesh, India. drskverma@rediffmail.com
BMJ Case Reports
|December 22, 2012
Summary
Kerosene aspiration causes severe lung damage, including inflammation and surfactant loss. This case highlights the risk of pyopneumothorax following kerosene consumption, emphasizing its pulmonary toxicity.
Area of Science:
- Toxicology
- Pulmonology
- Environmental Health
Background:
- Petroleum-derived liquid hydrocarbons, like those in kerosene, are common in households and industry.
- Kerosene contains toxic compounds (e.g., hexane, naphthalene, octane, phenanthrene) posing health risks.
- Pulmonary toxicity is a primary concern, leading to significant morbidity and mortality.
Observation:
- The major exposure route is inhalation of liquid (aspiration), not vapor.
- Kerosene aspiration triggers lung inflammation and surfactant depletion.
- Secondary pulmonary complications include pneumothorax, pneumatocele, and bronchopleural fistula.
Findings:
- This report details a specific case of pyopneumothorax.
- Pyopneumothorax developed subsequent to kerosene consumption.
- The case underscores the severe respiratory consequences of kerosene ingestion.
Implications:
- Highlights the critical need for public awareness regarding kerosene dangers.
- Informs clinical management strategies for hydrocarbon aspiration injuries.
- Emphasizes the importance of preventative measures to reduce accidental kerosene exposure.
More Related Videos
Related Concept Videos
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
01:26Pneumothorax-I
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
01:08Pneumothorax II: Pathophysiology
Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:17Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...